期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

胶质瘤干细胞化疗耐受性的研究进展 被引量：2

暂未订购
导出
摘要 近年的研究业已证实胶质瘤干细胞（glioma stem cells，GSCs）的存在，并对其生物学特性进行了较为深入的研究，化疗耐受性是其重要生物学特性之一。深入研究胶质瘤干细胞的化疗耐受性对改善胶质瘤患者的药物化疗效果具有重要临床意义。笔者拟就这方面的研究进展进行综述。
作者 胡胜利 杨丽娟 林志雄
机构地区 福建医科大学附属第一医院神经外科 福建医科大学药学院
出处 《中国现代神经疾病杂志》 CAS 2009年第2期184-186,共3页 Chinese Journal of Contemporary Neurology and Neurosurgery
基金 福建省科技计划项目(项目编号:2007I0014) 福建省新世纪优秀人才支持计划项目(项目编号:NCETFJ-0610) 福建省教育厅科技项目(项目编号:JXK200713)
关键词 神经胶质瘤 肿瘤干细胞 药物耐受性 综述文献
分类号 R739.4 [医药卫生—肿瘤]
  • 相关文献

参考文献16

  • 1李刚,陈忠平.脑胶质瘤药物化疗新进展[J].中国现代神经疾病杂志,2008,8(5):411-417. 被引量：9
  • 2林志雄,谭淑莲,周爱萍,梅文忠,何理盛,江常震,康德智.影响替莫唑胺治疗脑胶质瘤效果的非病理级别因素初步探讨[J].中国现代神经疾病杂志,2008,8(5):437-441. 被引量：8
  • 3Chen Lu,Amal Shervington.Chemoresistance in gliomas[J].Molecular and Cellular Biochemistry (-).2008(1-2)
  • 4Atsushi Natsume,Toshihiko Wakabayashi,Dai Ishii,Hideharu Maruta,Masazumi Fujii,Shinji Shimato,Motokazu Ito,Jun Yoshida.A combination of IFN-β and temozolomide in human glioma xenograft models: implication of p53-mediated MGMT downregulation[J].Cancer Chemotherapy and Pharmacology.2008(4)
  • 5Anshul Gupta,Yang Dai,R. Robert Vethanayagam,Mary F. Hebert,Kenneth E. Thummel,Jashvant D. Unadkat,Douglas D. Ross,Qingcheng Mao.Cyclosporin A, tacrolimus and sirolimus are potent inhibitors of the human breast cancer resistance protein (ABCG2) and reverse resistance to mitoxantrone and topotecan[J].Cancer Chemotherapy and Pharmacology.2006(3)
  • 6Antonio Silvani,Marica Eoli,Andrea Salmaggi,Elena Lamperti,Elio Maccagnano,Giovanni Broggi,Amerigo Boiardi.Phase II Trial of Cisplatin Plus Temozolomide, in Recurrent and Progressive Malignant Glioma Patients[J].Journal of Neuro - Oncology (-).2004(1-2)
  • 7Shervington A,Lu C.Expression of multidrug resistance genes innormal and cancer stem cells[].Cancer Investigation.2008
  • 8Beier D,Rhrl S,Pillai DR,et al.Temozolomide preferentiallydepletes cancer stem cells in glioblastoma[].Cancer Research.2008
  • 9Natsume A,Wakabayashi T,Ishii D,et al.A combination of IFN-beta and temozolomide in human glioma xenograft models:impli-cation of p53-mediated MGMT downregulation[].Cancer Chemotherapy and Pharmacology.2008
  • 10Reya T,Morrison SJ,Clarke MF,et al.Stem cells, cancer, and cancer stem cells[].Nature.2001

二级参考文献54

  • 1[1]Brada M,Viviers L.Abson C,et al.Phase Ⅱ study of primary temozolomide chemotherapy in patients with WHO grade Ⅱgliomas.Ann Oncol,2003,14:1715-1721.
  • 2[2]Frenay MP,Fontaine D,Vandenbos F,et al.First-line nitrosourea-based chemotherapy in symptomatic non-resectable supratentorial pure low-grade astrocytoma.Eur J Neurol,2005,12:685-690.
  • 3[3]Tosoni A,Franceschi E,Ermani M,et al.Temozolomide three weeks on and one week off as first line therapy for patients with recurrent or progressive low grade gliomas,J Neurooncol.2008.
  • 4[4]Eyre HJ,Crowley JJ,Townsend JJ.et al.A randomized trial of radiotherapy versus radiotherapy plus CCNU for incompletely resected low-grade gliomas:a Southwest Oncology Group study.J Neurosurg,1993,78:909-914.
  • 5[5]Radiation Therapy Ontology Group.A phaseⅡstudy of observation in favorable low-grade dioma and a phase iil study of radiation with or without PCV chemotherapy in unfavorable low.grade glioma[DB/OL].(2005-06)[2008-09-06]http://www.rtog.org/studysummary/062005 reprots/9802.pdf
  • 6[6]Schiff D,Brown PD,Giannini C.Outcome in adult low-grade glioma:the impact of prognostic factors and treatment.Neurology,2007,69:1366-1373.
  • 7[7]Kaloshi G,Benouaich-Amiel A.Diakite F.et al.Temozolomide for low-grade gliomas:predictive impact of 1p/19q loss on response and outcome.Neurology,2007,68:1831-1836.
  • 8[8]Medical Research Council Brain Tumor Working Party.Randomized trial of procarbazine,lomustine,and vincristine in the adjuvant treatment of high-grade astrocytom:a Medical Research Council trial.J Clin Oncol.2001,19:509-518.
  • 9[9]Stewart LA.Chemotherapy in adult high-grade glioma:a systematic review and meta-analysis of individual patient data from 12randomised trials.Lancet,2002,359:1011-1018.
  • 10[10]Wolff JE,Berrak S,Koontz Webb SE,et al.Nitrosourea efficacy in high-grade glioma:a survival gain analysis summarizing 504 cohorts with 24193 patients.J Neurooncol,2008,88:57-63.

共引文献15

同被引文献51

引证文献2

二级引证文献4

中国现代神经疾病杂志
2009年 第2期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部